Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Gazi University
Patients were diagnosed with pulmonary arterial hypertension according to the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of f the European Society of Cardiology (ESC) and European Respiratory Society (ERS). Primary outcome measurement was exercise capacity, secondary outcomes were respiratory and peripheral muscle strength, physical activity, quality of life, fatigue, dyspnea and depression.
Age
18–65
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Clinically stable
Under standard medication
Group 1 pulmonary arterial hypertension patients
Having no exacerbation or infection
You may not be if
Cognitive disorders
Orthopedic and neurological problems
Pneumonia or acute infection
Stage 4 heart failure
Having no comorbidity to avoid performing evaluation and training